Target (CBDY) Cash from Operations (2013 - 2026)
Target (CBDY) reported Cash from Operations of 93665.0 for Q1 2026, up 83.57% year-over-year from 51024.78 in Q1 2025, and up 62.65% quarter-over-quarter from 250788.0 in Q4 2025.
Target (CBDY) Cash from Operations (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Cash from Operations data on file, last reported at 93665.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 93665.0, up 83.57% year-over-year; the trailing twelve-month figure through Mar 2026 was 366085.0 (down 144.74% YoY), and the FY2025 annual result was 842425.0, down 138.95% from the prior year.
- Cash from Operations rose to 93665.0 in Q1 2026 per CBDY's latest filing, from 250788.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 981075.0 in Q2 2024 and troughed at 1356210.0 in Q3 2023.
- A 5-year average of 22226.24 and a median of 55377.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations tumbled 1151.53% in 2023, then jumped 514.68% in 2024.
- A 5-year view of Cash from Operations shows it stood at 55377.0 in 2022, then surged by 423.08% to 289668.0 in 2023, then surged by 154.23% to 736437.0 in 2024, then slumped by 134.05% to 250788.0 in 2025, then soared by 62.65% to 93665.0 in 2026.
- Business Quant data shows CBDY's Cash from Operations at 93665.0 in Q1 2026, 250788.0 in Q4 2025, and 506066.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Target | - | - | 191,787.00 | -93,665.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93,665.00 |
| Mar 31, 2026 | -93,665.00 |
| Dec 31, 2025 | -250,788.00 |
| Dec 31, 2025 | -250,788.00 |
| Sep 30, 2025 | -506,066.00 |
| Sep 30, 2025 | -506,066.00 |
| Jun 30, 2025 | 484,434.00 |
| Jun 30, 2025 | 484,434.00 |
| Mar 31, 2025 | -570,005.00 |
| Mar 31, 2025 | -570,005.00 |
| Dec 31, 2024 | 736,437.00 |
| Dec 31, 2024 | 736,437.00 |
| Sep 30, 2024 | -329,276.00 |
| Sep 30, 2024 | -329,276.00 |
| Jun 30, 2024 | 981,075.00 |
| Jun 30, 2024 | 981,075.00 |
| Mar 31, 2024 | 774,448.00 |
| Mar 31, 2024 | 774,448.00 |
| Dec 31, 2023 | 289,668.00 |
| Dec 31, 2023 | 289,668.00 |